- Home
- MSEX vs INBX Comparison
MSEX vs INBX Comparison
Compare MSEX & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MSEX | INBX |
|---|---|---|
| Founded | 1897 | 2010 |
| Country | United States | United States |
| Employees | 395 | N/A |
| Industry | Water Supply | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 999.7M |
| IPO Year | N/A | 2024 |
Fundamental Metrics
Financial Performance| Metric | MSEX | INBX |
|---|---|---|
| Price | $52.72 | $103.07 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | $61.33 | ★ $150.00 |
| AVG Volume (30 Days) | 93.3K | ★ 442.3K |
| Earning Date | 04-30-2026 | 05-15-2026 |
| Dividend Yield | ★ 2.77% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,300,000.00 |
| Revenue This Year | $10.60 | N/A |
| Revenue Next Year | $10.94 | N/A |
| P/E Ratio | $22.68 | ★ N/A |
| Revenue Growth | N/A | ★ 550.00 |
| 52 Week Low | $44.94 | $12.80 |
| 52 Week High | $62.18 | $155.29 |
Technical Indicators
Market Signals| Indicator | MSEX | INBX |
|---|---|---|
| Relative Strength Index (RSI) | 54.25 | 45.50 |
| Support Level | $51.83 | $99.20 |
| Resistance Level | $54.83 | $153.14 |
| Average True Range (ATR) | 1.09 | 11.61 |
| MACD | 0.17 | -3.13 |
| Stochastic Oscillator | 81.75 | 7.41 |
Price Performance
Historical ComparisonAbout MSEX Middlesex Water Company
Middlesex Water Co owns and operates regulated water utility and wastewater systems in the U.S. The company has two operating segments, Regulated and Non-Regulated. The regulated business includes collecting and distributing water to residential, commercial, industrial, and fire protection consumers. The non-regulated business includes contract services for the operation of private water and wastewater systems. The majority of the company's revenue is derived from the Regulated segment and from residential customers.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.